Patents by Inventor Ruth Kelly

Ruth Kelly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Shock resistant cyanoacrylate compositions
    Publication number: 20060094833
    Abstract: This invention relates to cyanoacrylate-containing compositions that exhibit at least one of improved shock resistance and bond strength, while demonstrating relative surface insensitivity with respect to establishing and maintaining fixture times that are on the order of comparable cyanoacrylate compositions without the added carboxylic acids. The compositions include, in addition to the cyanoacrylate component, certain carboxylic acids.
    Type: Application
    Filed: May 3, 2005
    Publication date: May 4, 2006
    Inventors: Patrick McDonnell, Robert Lambert, Ruth Kelly, Fergal Tierney
  • Interleukin-2 mutein expressed from mammalian cells
    Patent number: 6927043
    Abstract: Glycosylated interleukin-2 muteins are described. A method of producing the muteins using mammalian cells is included. The muteins may be incorporated into pharmaceutical preparations useful for, e.g., cancer therapy.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: August 9, 2005
    Assignee: Bayer Corporation
    Inventors: Sham-Yuen Chan, Ruth Kelly
  • Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
    Publication number: 20050048608
    Abstract: The present invention relates to a method for increased production of a secreted, recombinant protein product through the introduction of molecular chaperones in a mammalian host cell. The present invention also relates to a mammalian host cell with enhanced expression of a secreted recombinant protein product by coexpressing at least one chaperone protein.
    Type: Application
    Filed: March 3, 2004
    Publication date: March 3, 2005
    Inventors: Sham-Yuen Chan, Hsinyi Tang, Yiwen Tao, Yongjian Wu, Ruth Kelly
  • Cyanoacrylate compositions
    Patent number: 6835789
    Abstract: This invention relates to cyanoacrylate-containing compositions that include, in addition to the cyanoacrylate component, certain accelerators to improve fixture speeds on certain substrates.
    Type: Grant
    Filed: June 18, 2003
    Date of Patent: December 28, 2004
    Assignee: Loctite (R&D) Limited
    Inventors: Brendan J. Kneafsey, Ruth A. Kelly, Fergal W. Tierney, David P. Birkett, Hanns R. Misiak, Kieran Mulcahy, Harry J. Woolfson
  • CYANOACRYLATE COMPOSITIONS
    Publication number: 20040260045
    Abstract: This invention relates to cyanoacrylate-containing compositions that include, in addition to the cyanoacrylate component, certain accelerators to improve fixture speeds on certain substrates.
    Type: Application
    Filed: June 18, 2003
    Publication date: December 23, 2004
    Applicant: LOCTITE (R&D) LTD.
    Inventors: Brendan J. Kneafsey, Ruth A. Kelly, Fergal W. Tierney, David P. Birkett, Hanns R. Misiak, Kieran Mulcahy, Harry J. Woolfson
  • Interleukin-2 mutein expressed from mammalian cells
    Publication number: 20020164300
    Abstract: Glycosylated interleukin-2 muteins are described. A method of producing the muteins using mammalian cells is included. The muteins may be incorporated into pharmaceutical preparations useful for, e.g., cancer therapy.
    Type: Application
    Filed: January 22, 2002
    Publication date: November 7, 2002
    Inventors: Sham-Yuen Chan, Ruth Kelly
  • Interleukin-2 mutein expressed from mammalian cells
    Patent number: 6348192
    Abstract: Glycosylated interleukin-2 muteins are described. A method of producing the muteins using mammalian cells is included. The muteins may be incorporated into pharmaceutical preparations useful for, e.g., cancer therapy.
    Type: Grant
    Filed: May 11, 1999
    Date of Patent: February 19, 2002
    Assignee: Bayer Corporation
    Inventors: Sham-Yuen Chan, Ruth Kelly